PolicyX.com
InsurTech · Insurance Aggregator
Interested in this stock?
Valuation
₹500 – 900 Cr
Unlisted Price
₹60
52-Week Range
₹45 – ₹80
Expected IPO
TBD
About
India's leading online insurance comparison and purchase platform; profitable InsurTech with growing share of the fast-expanding digital insurance distribution market.
Key Highlight
Profitable online insurer aggregator; +5.3% recent price gain
Financial Ratios & Metrics
Detailed financial data is not yet available for this company.
Financial disclosures for unlisted entities are limited until DRHP filing.
Share Information
IPO Details
Tags
Latest News
Auto-updated · Google NewsNews sourced from Google News RSS. Headlines link to original publishers.
More news →Frequently Asked Questions
What is the current unlisted share price of PolicyX.com?▾
The current indicative unlisted share price of PolicyX.com is ₹60, with a 52-week range of ₹45 – ₹80. This is a grey market price and not exchange-regulated.
When is the PolicyX.com IPO expected?▾
PolicyX.com has not announced a confirmed IPO timeline yet. Current IPO status is: Not Filed.
What is the valuation of PolicyX.com?▾
PolicyX.com is valued at approximately ₹500 – 900 Cr ($60–108M). This is a pre-IPO estimate based on grey market data and analyst reports.
What sector does PolicyX.com operate in?▾
PolicyX.com operates in the InsurTech — specifically Insurance Aggregator sector. Key highlight: Profitable online insurer aggregator; +5.3% recent price gain
Is PolicyX.com a good pre-IPO investment?▾
PolicyX.com is tracked on The Finance Network as a pre-IPO research subject. Key data: valuation ₹500 – 900 Cr, IPO status Not Filed, expected listing TBD. This is not investment advice — always consult a SEBI-registered adviser.
Disclaimer: All data is sourced from publicly available filings, analyst reports, and grey market platforms. Unlisted share prices are indicative and not exchange-regulated. Financial ratios for unlisted companies are estimated and may differ from audited figures. This is not investment advice. Read full disclaimer →